SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as investors digest a surge in price and speculative buzz about potential institutional adoption and favorable regulatory shifts, keeping community sentiment intensely bullish. Traders are closely monitoring the $80,000 level as a key psychological and technical benchmark for further momentum.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is attracting significant attention as investors react to official signals regarding its expansion into U.S. markets. The community is buzzing over its unique fee-burning mechanism, driving high conviction among bulls who view it as a top-tier institutional asset.

TOSHI

TOSHI is trending as the community speculates on a potential short squeeze and anticipates upcoming catalyst news from the project team. Investors remain focused on breaking key resistance levels while discussing the broader momentum of meme coins within the Base ecosystem.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural gas traders are actively debating price direction as the market balances strong production levels and storage builds against anticipated seasonal heat demand and the impact of the ongoing Freeport LNG maintenance. The community remains divided, with some betting on a short squeeze while others focus on leveraged decay and the long-term trend of oversupply.

Ethena

Ethena is generating significant buzz due to institutional interest and its integration into sophisticated capital infrastructure, with many community members highlighting its potential as a core asset in the growing synthetic dollar ecosystem. Investors are actively discussing the impact of secured lending arrangements and large-scale treasury strategies on the token's long-term utility and market performance.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors discuss its potential to rally back above the one-cent resistance level, with community sentiment split between frustration over price stagnation and long-term optimism regarding its brand IP. Many are comparing its current momentum to other major meme coins and eagerly tracking volume for signs of a potential breakout.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Investors are increasingly bullish on silver as the iShares Silver Trust (SLV) tracks broader precious metals gains, driven by community concerns over the U.S. debt spiral, persistent inflation, and the potential for aggressive Treasury bond buybacks. Many traders view physical silver as a strategic hedge against currency debasement, with ongoing discussions centered on a technical breakout and the potential for significant long-term appreciation.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

Natural gas is currently experiencing significant volatility and price weakness due to a combination of strong production levels and seasonally high storage injections, which are keeping upward momentum capped despite geopolitical tensions in the Middle East. The community is actively debating the effectiveness of leveraged ETFs like BOIL and KOLD, with many traders emphasizing the risks of decay and contango while discussing strategic pivots between the two symbols.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is seeing significant community discussion and market volatility following reports that AI-driven agentic commerce could potentially disrupt traditional interchange fee models. Investors are weighing these disruptive AI threats against the company's resilient transaction volume and its ongoing expansion into stablecoin infrastructure.

Cash Cat

Cash Cat is generating significant buzz as traders debate its potential as a flagship memecoin on the Robinhood network, with the community actively split between bullish accumulation and concerns over price volatility and platform fees. Sentiment remains focused on the token's role within the emerging Robinhood ecosystem, with many investors comparing its growth potential to established meme sector leaders.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell Lung Cancer

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that, on August 12, 2026, its partner Akeso Inc. (Akeso, HKEX Code: 9926.HK) announced receipt of marketing authorization in China from the National Medical Products Administration (NMPA) for the use of ivonescimab, a novel, potential...

RVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View

Revolution Medicines posts a wider-than-expected loss in Q2 and raises its 2026 expense outlook again as investors weigh higher spending and pipeline progress.

Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the expansion of its global registration-enabling clinical development program for the novel, potential first-in-class investigational bispecific antibody ivonescimab, into urothelial carcinoma, or bladder cancer, with the initiation of the...

Jim Cramer Calls Summit Therapeutics A 'Great Spec,' Recommends Buying This Consumer Cyclical Stock

"Mad Money" host Jim Cramer recommends buying Carvana and Summit Therapeutics. Reddit "surprised" him. Here's why.read more...

Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm PR Newswire NEW YORK, July 27, 2026 NEW YORK, July 27, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

SMMT Stock Heads For Third Straight Weekly Drop – Analyst Tempers Expectations From Initial Lung Cancer Trial Survival Data

Equity

The biotech firm stated that enrollment in both the squamous and non-squamous cohorts in its Harmoni-3 trial to treat metastatic non-small cell lung cancer is complete.

SMMT's Q2 Loss Wider Than Expected, Ivonescimab Development in Focus

Summit posts a wider Q2 loss with no revenues as ivonescimab advances through late-stage studies, undergoes FDA review & gains new development collaborations.

Deckers Outdoor, Summit Therapeutics, Robert Half And Other Big Stocks Moving Lower In Friday's Pre-Market Session

US stock futures higher, Deckers Outdoor shares fall after reporting Q1 results. Other stocks also down in pre-market trading. Photo via Shutterstock.read more...

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026

Summit Therapeutics Inc. (NASDAQ: SMMT) today reported its financial results for the second quarter and six months ended June 30, 2026 and provided an update on clinical and operational progress. The clinical momentum of ivonescimab continues to build, with two recent key data readouts that...

FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer 

Revolution Medicines' FDA filing for daraxonrasib in metastatic pancreatic cancer enters an accelerated review program, bringing its first commercial product closer.

$SMMT Q2 '26 Earnings Results & Recap

Reported GAAP EPS of -$0.28 up 63.16% YoY

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SMMT Summit Therapeutics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SMMT News